Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Ranexa (Ranolazine) Extended-Release
Company:  CV Therapeutics, Inc.
Application No.:  021526
Approval Date: 01/27/2006


Date created: April 062006

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.